Status:
UNKNOWN
Prevalence of Peripheral Vascular Diseases and Presentation in Patients With Autoimmune Diseases
Lead Sponsor:
Hossam Adly Mohamed
Conditions:
Peripheral Vascular Diseases and Presentation in Patient With Autoimmune Diseases
Eligibility:
All Genders
Brief Summary
Rheumatic autoimmune diseases include conditions such as systemic lupus rheumatoid arthritis systemic sclerosis in which connective tissues are frequently targeted. Autoimmune diseases as a group are...
Eligibility Criteria
Inclusion
- all ages
- Both sexes
- Recent or past history of vascular diseases or presentation in any proven autoimmune diseases according to the guidlines.
Exclusion
- patients refuse the study
- patients do not have established diagnosis of vascular diseases .
- patients not completely approved to have autoimmune diseases.
Key Trial Info
Start Date :
September 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 10 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06169865
Start Date
September 10 2023
End Date
May 10 2024
Last Update
December 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt